Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Recruiting 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3Head & Neck 2Gastrointestinal 2Thoracic 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 64Lung Neoplasms 27Triple Negative Breast Neoplasms 19Squamous Cell Carcinoma of Head and Neck 16Breast Neoplasms 16Small Cell Lung Carcinoma 12Parkinson Disease 4, Autosomal Dominant Lewy Body 12Ovarian Neoplasms 12Fallopian Tube Neoplasms 12Endometrial Neoplasms 11Neoplasms 9Neoplasm Metastasis 6Carcinoma 6Oropharyngeal Neoplasms 5Urinary Bladder Neoplasms 4Mouth Neoplasms 4Lung Diseases 4Laryngeal Neoplasms 4Head and Neck Neoplasms 4Colorectal Neoplasms 4Adenocarcinoma of Lung 4Uterine Cervical Neoplasms 3Respiratory Tract Neoplasms 3Prostatic Neoplasms 3Mesothelioma 3Hypopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Central Nervous System Neoplasms 3Carcinoma, Ovarian Epithelial 3Advanced Solid Tumors 3

Interventions

pembrolizumab 7Specimen Handling 6Human Papillomavirus DNA Tests 4Colposcopy 4Paclitaxel 3Magnetic Resonance Spectroscopy 3Fulvestrant 3Cisplatin 3Carboplatin 3palbociclib 2lenvatinib 2Surveys and Questionnaires 2Radiation Dose Hypofractionation 2Nivolumab 2Magnetic Resonance Imaging 2Gemcitabine 2Biopsy 2Bevacizumab 2ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1tisotumab vedotin 1sapanisertib 1ribociclib 1relatlimab 1pertuzumab 1patritumab deruxtecan 1osimertinib 1omipalisib 1liposomal doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × Carboplatin × 30 days × Clear all
NCT06535607 2026-05-26

eVOLVE-02

AstraZeneca

Phase 2 Recruiting
257 enrolled
GastrointestinalGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Uterine Cervical Neoplasms

NCT07216703 2026-05-22

TroFuse-036

Merck Sharp & Dohme LLC

Phase 3 Recruiting
1,023 enrolled
Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Uterine Cervical Neoplasms

NCT04389632 2026-05-11

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Seagen Inc.

Phase 1 Recruiting
1,006 enrolled
GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Adenocarcinoma Of Esophagus, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡